SEARCH

SEARCH BY CITATION

References

  • 1
    NICE, Menstrual bleeding—fluid-filled thermal balloon and microwave endometrial ablation, Technology Appraisal 78. 2004 [www.nice.org.uk]. Accessed 1 April 2013.
  • 2
    Meyer W, Walsh B, Grainger D, Peacock L, Loffer F, Steege J. Thermal balloon and rollerball ablation to treat menorrhagia: a multicenter comparison. Obstet Gynecol 1998;92:98103.
  • 3
    Cooper KG, Bain C, Parkin DE. Comparison of microwave endometrial ablation and transcervical resection of the endometrium for treatment of heavy menstrual loss: a randomised trial. Lancet 1999;354:185963.
  • 4
    Cooper KG, Bain C, Lawrie L, Parkin DE. A randomised comparison of microwave endometrial ablation with transcervical resection of the endometrium; follow up at a minimum of five years. BJOG 2005;112:4705.
  • 5
    Sambrook AM, Bain C, Parkin D, Cooper KG. A randomised comparison of MEA with TCRE; follow up at a minimum of ten years. BJOG 2009;116:10337.
  • 6
    Kleijn JH, Engels R, Bourdrez P, Mol BWJ, Bongers MY. Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation. BJOG 2008;115:1938.
  • 7
    Sambrook AM, Cooper KG, Campbell MK, Cook JA. Clinical outcomes from a randomised comparison of Microwave Endometrial Ablation with Thermal Balloon endometrial ablation for the treatment of heavy menstrual bleeding. BJOG 2009;116:103845.
  • 8
    Kilonzo MM, Sambrook AM, Cook JA, Campbell MK, Cooper KG. A Cost–utility analysis of microwave endometrial ablation versus thermal balloon endometrial ablation. Value Health 2010;13:52834.
  • 9
    Altman DG, Machin D, Bryant T, Gardiner M. Statistics with Confidence, 2nd edn. Bristol: BMJ Books; 2002.
  • 10
    Ware JE, Kosinski M, Turner-Bowker DM, Gandek B. How to Score Version 2 of the SF12 Health Survey (with a Supplement Documenting Version 1). Lincoln, RI: Quality Metric Incorporated; 2002.
  • 11
    Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332.
  • 12
    Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. for the CONSORT Group. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trial. BMJ 2010;340:c869.
  • 13
    Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. for the CONSORT Group. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trial. J Clin Epidemiol 2010;63:e137.
  • 14
    Jenkinson C, Peto V, Coulter A. Measuring change over time: a comparison of results from a global single item of health status and the multi-dimensional SF-36 health status survey questionnaire in patients presenting with menorrhagia. Qual Life Res 1994;3:31721.
  • 15
    Cooper KG, Parkin DE, Garratt AM, Grant AM. A randomised comparison of medical and hysteroscopic management in women consulting a gynaecologist with heavy menstrual loss. Br J Obstet Gynaecol 1997;104:13606.
  • 16
    Johnson JA, Pickard AS. Alberta-Based SF-12 Summary Scores. Working Paper 98-2. Edmonton, AB: Institute of Pharmaco-Economics, 1998. pp. 124.
  • 17
    Herman MC, Penninx JP, Mol BW, Bongers MY. Ten-year follow-up of a randomised controlled trial comparing bipolar endometrial ablation with balloon ablation for heavy menstrual bleeding. BJOG 2013;120:96670.
  • 18
    Glasser MH. Commentary on ‘Ten-year follow-up of a randomised controlled trial comparing bipolar endometrial ablation with balloon ablation for menorrhagia. BJOG 2013;120:970.
  • 19
    Cooper K, Lee A, Chien P, Raja E, Timmaraju V, Bhattacharya S. Outcomes following hysterectomy or endometrial ablation for heavy menstrual bleeding: retrospective analysis of hospital episode statistics in Scotland. BJOG 2011;118:11719.